Incyte Corp (INCY)
51.18
-0.56
(-1.08%)
USD |
NASDAQ |
Apr 25, 16:00
51.18
0.00 (0.00%)
After-Hours: 20:00
Incyte Price to Book Value: 2.214 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 2.214 |
| April 24, 2024 | 2.238 |
| April 23, 2024 | 2.234 |
| April 22, 2024 | 2.246 |
| April 19, 2024 | 2.265 |
| April 18, 2024 | 2.285 |
| April 17, 2024 | 2.281 |
| April 16, 2024 | 2.302 |
| April 15, 2024 | 2.312 |
| April 12, 2024 | 2.330 |
| April 11, 2024 | 2.376 |
| April 10, 2024 | 2.379 |
| April 09, 2024 | 2.392 |
| April 08, 2024 | 2.382 |
| April 05, 2024 | 2.390 |
| April 04, 2024 | 2.379 |
| April 03, 2024 | 2.393 |
| April 02, 2024 | 2.415 |
| April 01, 2024 | 2.450 |
| March 28, 2024 | 2.465 |
| March 27, 2024 | 2.471 |
| March 26, 2024 | 2.446 |
| March 25, 2024 | 2.487 |
| March 22, 2024 | 2.465 |
| March 21, 2024 | 2.497 |
| Date | Value |
|---|---|
| March 20, 2024 | 2.520 |
| March 19, 2024 | 2.524 |
| March 18, 2024 | 2.481 |
| March 15, 2024 | 2.525 |
| March 14, 2024 | 2.533 |
| March 13, 2024 | 2.549 |
| March 12, 2024 | 2.567 |
| March 11, 2024 | 2.630 |
| March 08, 2024 | 2.597 |
| March 07, 2024 | 2.554 |
| March 06, 2024 | 2.564 |
| March 05, 2024 | 2.548 |
| March 04, 2024 | 2.584 |
| March 01, 2024 | 2.555 |
| February 29, 2024 | 2.525 |
| February 28, 2024 | 2.595 |
| February 27, 2024 | 2.639 |
| February 26, 2024 | 2.619 |
| February 23, 2024 | 2.621 |
| February 22, 2024 | 2.635 |
| February 21, 2024 | 2.61 |
| February 20, 2024 | 2.545 |
| February 16, 2024 | 2.508 |
| February 15, 2024 | 2.551 |
| February 14, 2024 | 2.504 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.214
Minimum
Apr 25 2024
12.22
Maximum
Jun 22 2020
5.627
Average
4.785
Median
Oct 01 2021
Price to Book Value Benchmarks
| Novartis AG | 5.094 |
| MorphoSys AG | 50.29 |
| Illumina Inc | 3.348 |
| Biogen Inc | 1.938 |
| Pfizer Inc | 1.602 |
Price to Book Value Related Metrics
| PE Ratio | 19.31 |
| PS Ratio | 3.129 |
| PEG Ratio | 0.2598 |
| Price to Free Cash Flow | 25.76 |
| Price | 51.18 |
| Earnings Yield | 5.18% |
| Market Cap | 11.49B |
| PEGY Ratio | 0.2598 |
| Operating PE Ratio | 17.80 |
| Normalized PE Ratio | 19.65 |